Letter to the Editor: Pregnant Women and their Providers Want Direct-Acting Antivirals, and We Are Missing the Mark
- PMID: 33959998
- DOI: 10.1002/hep.31885
Letter to the Editor: Pregnant Women and their Providers Want Direct-Acting Antivirals, and We Are Missing the Mark
Comment in
-
REPLY.Hepatology. 2021 Oct;74(4):2312-2313. doi: 10.1002/hep.31887. Epub 2021 Jul 29. Hepatology. 2021. PMID: 33959991 No abstract available.
Comment on
-
Responsible Inclusion of Pregnant Individuals in Eradicating HCV.Hepatology. 2021 Sep;74(3):1645-1651. doi: 10.1002/hep.31825. Epub 2021 Jun 4. Hepatology. 2021. PMID: 33743550
References
-
- Jhaveri R, Yee LM, Antala S, Murphy M, Grobman WA, Shah SK, et al. Responsible inclusion of pregnant individuals in eradicating hepatitis C virus. Hepatology 2021;74:1645-1651.
-
- The American College of Obstetricians and Gynecologist. Routine hepatitis C virus screening in pregnant individuals. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articl.... Published May 2021. Accessed June 2021.
-
- American Association for the Study of Liver Diseases, Infectious Diseases Society of America. HCV Guidance: Recommendations for testing, managing, and treating hepatitis C. HCV in pregnancy. https://www.hcvguidelines.org/unique-populations/pregnancy. Published August 27, 2020. Accessed April 7, 2021.
-
- Kushner T, Cohen J, Tien PC, Terrault NA. Evaluating women's preferences for hepatitis C treatment during pregnancy. Hepatol Commun 2018;2:1306-1310.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
